These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9723396)

  • 61. A novel immunosuppressive strategy combined with preemptive antiviral therapy improves the eighteen-month mortality in HCV recipients transplanted with aged livers.
    Urbani L; Mazzoni A; Colombatto P; Bindi L; Biancofiore G; Tascini C; Menichetti F; Brunetto MR; Scatena F; Filipponi F
    Transplantation; 2008 Dec; 86(12):1666-71. PubMed ID: 19104402
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Steroid minimization in liver transplant recipients: impact on hepatitis C recurrence and post-transplant diabetes.
    Humar A; Crotteau S; Gruessner A; Kandaswamy R; Gruessner R; Payne W; Lake J
    Clin Transplant; 2007; 21(4):526-31. PubMed ID: 17645714
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Allografts positive for hepatitis B surface antigen in liver transplant for disease related to hepatitis B virus.
    Ju W; Chen M; Guo Z; Wang D; Zhu X; Huang J; He X
    Exp Clin Transplant; 2013 Jun; 11(3):245-9. PubMed ID: 23176583
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Repeated steroid pulse therapies in HCV-positive liver recipients: significant risk factor for HCV-related graft loss.
    Bahra M; Neumann UP; Jacob D; Langrehr JM; Neuhaus P
    Transplant Proc; 2005 May; 37(4):1700-2. PubMed ID: 15919436
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Fibrosing cholestatic hepatitis in a liver transplant recipient with hepatitis C virus infection: a case report.
    Furuta K; Takahashi T; Aso K; Hoshino H; Sato K; Kakita A
    Transplant Proc; 2003 Feb; 35(1):389-91. PubMed ID: 12591454
    [No Abstract]   [Full Text] [Related]  

  • 66. A prospective randomized trial of mycophenolate mofetil in liver transplant recipients with hepatitis C.
    Jain A; Kashyap R; Demetris AJ; Eghstesad B; Pokharna R; Fung JJ
    Liver Transpl; 2002 Jan; 8(1):40-6. PubMed ID: 11799484
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Survival outcome after hepatic retransplantation for hepatitis C virus-positive and -negative recipients.
    Jain A; Orloff M; Abt P; Kashyap R; Mohanka R; Lansing K; Romano J; Bozorgzadeh A
    Transplant Proc; 2005 Sep; 37(7):3159-61. PubMed ID: 16213336
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Renal transplantation in patients positive for hepatitis B or C (pro).
    Morales JM
    Transplant Proc; 1998 Aug; 30(5):2064-9. PubMed ID: 9723394
    [No Abstract]   [Full Text] [Related]  

  • 69. Hepatitis C recurrence in liver transplant recipients.
    Kizilisik TA; al-Sebayel M; Hammad A; al-Traif I; Ramirez CG; Abdulla A
    Transplant Proc; 1997 Nov; 29(7):2875-7. PubMed ID: 9365599
    [No Abstract]   [Full Text] [Related]  

  • 70. Long-term outcome of hepatitis C infection after liver transplantation.
    Gane EJ; Portmann BC; Naoumov NV; Smith HM; Underhill JA; Donaldson PT; Maertens G; Williams R
    N Engl J Med; 1996 Mar; 334(13):815-20. PubMed ID: 8596547
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Recurrence of hepatitis C in liver transplant recipients treated with mycophenolate mofetil.
    Fasola CG; Netto GJ; Jennings LW; Christensen LL; Molmenti EP; Sanchez EQ; Levy MF; Goldstein RM; Klintmalm GB
    Transplant Proc; 2002 Aug; 34(5):1563-4. PubMed ID: 12176486
    [No Abstract]   [Full Text] [Related]  

  • 72. Is lamivudine with 1-week HBlg as effective as long-term high-dose HBlg in HBV prophylaxis after liver transplantation?
    Park SJ; Paik SW; Choi MS; Lee JH; Koh KC; Kim SJ; Joh JW; Lee SK
    Transplant Proc; 2002 Jun; 34(4):1252-4. PubMed ID: 12072331
    [No Abstract]   [Full Text] [Related]  

  • 73. Long-term follow-up in hepatitis C patients with respect to immunosuppression.
    Mueller AR; Platz KP; Berg T; Fukomoto T; Guckelberger O; Neuhaus R; Bechstein WO; Hopf U; Lobeck H; Neuhaus P
    Transplant Proc; 1996 Dec; 28(6):3241-2. PubMed ID: 8962255
    [No Abstract]   [Full Text] [Related]  

  • 74. Comparison between tacrolimus and neoral cyclosporine administered by oral route in liver transplantation.
    Bilbao I; Pou L; Allende E; Lázaro JL; Charco R; Hidalgo E; Margarit C
    Transplant Proc; 2001 May; 33(3):2124-6. PubMed ID: 11377472
    [No Abstract]   [Full Text] [Related]  

  • 75. Orthotopic liver transplantation for hepatitis C: outcome, effect of immunosuppression, and causes of retransplantation during an 8-year single-center experience.
    Ghobrial RM; Farmer DG; Baquerizo A; Colquhoun S; Rosen HR; Yersiz H; Markmann JF; Drazan KE; Holt C; Imagawa D; Goldstein LI; Martin P; Busuttil RW
    Ann Surg; 1999 Jun; 229(6):824-31; discussion 831-3. PubMed ID: 10363896
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Liver transplantation for viral hepatitis: the experience of the hepatobiliary center at Hospital Paul Brousse.
    Samuel D; Feray C; Bismuth H
    Clin Transpl; 1994; ():157-62. PubMed ID: 7547534
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Predictive factors of outcome in patients transplanted for hepatitis B.
    Beckebaum S; Sotiropoulos GC; Klein CG; Broelsch CE; Saner F; Paul A; Gerken G; Cicinnati VR
    Transplantation; 2009 Mar; 87(6):872-81. PubMed ID: 19300191
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Ten-year follow-up of kidney transplantation from hepatitis B surface antigen-positive donors.
    Sumethkul V; Ingsathit A; Jirasiritham S
    Transplant Proc; 2009; 41(1):213-5. PubMed ID: 19249516
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Prophylaxis against hepatitis B recurrence following liver transplantation in HBs Ag(+) patients.
    Lee SK; Park JH; Joh JW; Kim SJ; Choi IS; Choi SH; Heo JS; Lee WY; Sohn TS; Kim YI; Paik SW; Koh KC; Lee JH; Kim SM; Peck KR; Song JH; Lee BB
    Transplant Proc; 2000 Nov; 32(7):2248-9. PubMed ID: 11120152
    [No Abstract]   [Full Text] [Related]  

  • 80. Evaluation of liver transplantation for high-risk indications.
    Chung SW; Greig PD; Cattral MS; Taylor BR; Sheiner PA; Wanless I; Cameron R; Phillips MJ; Blendis LM; Langer B; Levy GA
    Br J Surg; 1997 Feb; 84(2):189-95. PubMed ID: 9052430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.